ArticleOPEN ACCESS

Targeted immunotherapy in Hodgkin lymphoma

Blood
DOI: 10.1182/blood-2015-05-641712
1Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Rothe et al introduce a new principle of targeted Hodgkin lymphoma (HL) immunotherapy in their report from a phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13.

Cite

CITATION STYLE

APA

Hutchings, M. (2015, June 25). Targeted immunotherapy in Hodgkin lymphoma. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2015-05-641712

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free